![Christopher Stevens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 30/06/2026
Christopher Stevens is Chief Operating Officer at Rocket Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Stevens was Chief Patent Supply Officer & Executive VP at Spark Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Purdue University and graduate studies at the University of Southern Indiana.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/02/2026 | 469.129 ( 0,43% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Direttore operativo | 07/07/2025 |
| Società | Posizione | Fine |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
 University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
